Richard A. Heyman - Director at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
ELVN on Nasdaq
All Insider Reports
All Insider Reports

Richard A. Heyman - trading volume in the past year for Enliven Therapeutics, Inc.

Holdings reported by Richard A. Heyman for Enliven Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 123,673 $3,138,820 $25.38 17 Feb 2026 Direct
Common Stock 22,647 $592,805 $26.18 17 Feb 2026 Indirect
Stock Option (right to buy) 19,234 12 Feb 2026 Direct Common Stock

Transactions reported by Richard A. Heyman for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.